Clinician-ready guidance
Clear recommendations translating neuronal + genomic signals into practical treatment selection for MDD.
An AI-enabled paradigm for precision medicine in CNS diseases
We harness Nobel-Prize winning technology to generate iPSC-derived neurons from each individual, enabling clinicians to identify the most effective treatment for each patient based on the unique response of each patient's brain cells combined with genetics and medical history.
Each individual's own brain cells, derived from a simple blood sample, informs their optimal treatment
AI and computer vision applied on
multi-modal data for unprecedented accuracy
A robust repository with hundreds of thousands of data points from diverse patient profiles across multiple conditions
Our platform is built on the largest and most comprehensive databank combining advanced neuronal imaging, genomic profiles, and real-world clinical data from patient-derived neurons.
NeuroKaire (formerly Genetika+) is transforming psychiatry & neurology care by providing patients, physicians, drug developers and researchers, for the first time, an approach to precision medicine through the lense of each patient’s unique neurobiology, with deep actionable mechanistic insight into disease and patient characteristics.
NeuroKaire’s evidence-based tests and services offer the quality and commitment you need to help guide treatment strategies for your psychiatry and neurology diseases' patients.
From discovery to clinical trials and launch, we are your ideal partner in validating compounds ad accelerating therapeutic breakthroughs. Our cell-based precision platform helps transform promising therapies into new standards of care.
We are committed to providing specific cell-based insights into your psychiatric or neurological disorder to help your doctor guide a personalized care plan.